TOKYO -- Japan is gearing up to produce AstraZeneca COVID-19 shots as it grows desperate to secure enough vaccine for its population of 126 million amid global supply constraints, Nikkei has learned.
Production will be undertaken by JCR Pharmaceuticals, a biotechnology company that does not have experience producing vaccines but can culture the necessary adenoviral vectors.
